P075 CHEMICAL STABILITY OF THIOPURINE METABOLITES IN ERYTHROCYTES DURING 6-MERCAPTOPURINE AND AZATHIOPRINE TREATMENT

Peer de Graaf(American Pharmacists Association), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Bindia Jharap(Meander Medisch Centrum), René Vos(Amsterdam UMC Location Vrije Universiteit Amsterdam), Arno Sinjewel(Amsterdam UMC Location Vrije Universiteit Amsterdam), Agnes I. Veldkamp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Nanne K.H. de Boer
Journal of Crohn s and Colitis Supplements
March 1, 2007
10.1016/s1873-9954(07)70087-3
Cited by 0

Related Papers

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
|The Lancet|2022|301
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
|Gut|2019|221
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
|Inflammatory Bowel Diseases|2010|199
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
|Journal of Crohn s and Colitis|2019|183